Journal of Cardiovascular Electrophysiology Publishes Special Issue Dedicated to Stereotaxis Technology
March 11, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 11, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the Journal...
Stereotaxis Reports 2015 Fourth Quarter and Full Year Financial Results
February 22, 2016 16:05 ET
|
Stereotaxis, Inc.
New capital orders of $5.1 million in the fourth quarter, including two Niobe® ES system orders in JapanFourth quarter free cash flow of $1.6 million, driving a 71% reduction in full year cash burn...
Stereotaxis to Participate at BTIG’s 2016 MedTech Conference
February 16, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that William C....
Stereotaxis to Report Fourth Quarter and Full Year 2015 Financial Results on February 22, 2016
February 08, 2016 06:30 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 08, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it will...
University Medical Center New Orleans Implements Stereotaxis Platform for Advanced Treatment of Cardiac Arrhythmias
February 01, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 01, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, and University Medical Center...
Stereotaxis and Philips Extend Development Collaboration to Interface Latest Systems
January 26, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS and BEST, The Netherlands, Jan. 26, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS) today announced Stereotaxis and Philips have signed an addendum pursuant to their existing...
Stereotaxis Initiates Multi-Center Randomized Superiority Study on Ventricular Tachycardia Ablation Outcomes
January 11, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it has...
Multicenter Study Reveals Improved Long-Term Success Rates With Stereotaxis Technology in Ventricular Tachycardia
November 17, 2015 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 17, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the results of an...
Stereotaxis Reports 2015 Third Quarter Financial Results
November 03, 2015 16:05 ET
|
Stereotaxis, Inc.
-Total Quarterly Revenue Increased 5% Year over Year on Improved System and Recurring Revenues- -Total Revenue for First Nine Months Increased 13% Year over Year to $28.5...
Stereotaxis to Report Third Quarter 2015 Financial Results on November 3, 2015
October 27, 2015 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it will...